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Greater social withdrawal is related to higher levels of psychological distress and poorer 
adaptation to a diagnosis of amyotrophic lateral sclerosis.  
Objectives 
To examine whether demographics and functional deficits can be used to assess which 
patients may be at risk of social withdrawal and whether symptoms including 
depression and anxiety can provide additional information for identifying individuals at 
risk. Furthermore, to examine whether patient-perceived stigma has a role in mediating 
the effects of any of the predictors of social withdrawal.  
Methods  
559 participants in the ongoing Trajectories of Outcomes in Neurological Conditions 
(TONiC) study completed a questionnaire pack collecting data on demographics and a 
range of patient reported measures. Multiple regression analysis was employed to assess 
associations of functional ability, demographics, physical symptoms, anxiety, and 
depression with social withdrawal. The mediating role of stigma was assessed through 
the development of a bivariate linear regression model for stigma and social withdrawal. 
Results 
Disability in the bulbar and motor domains, anxiety and depression were found to be 
significant predictors of social withdrawal. Stigma was the strongest single predictor of 
social withdrawal and was found to partially mediate the effects of functional deficits 




Social withdrawal is associated with worse motor disability and poorer bulbar 
function, as well as increased anxiety and depression. Stigma is a powerful 
predictor for social withdrawal; further work should investigate whether stigma is 
a potential target for psychological interventions aimed at reducing social 
withdrawal and improving quality of life. 






Amyotrophic lateral sclerosis (ALS), or motor neurone disease (MND), is a disease of 
progressive degeneration of the motor neurones in the brain and spinal cord causing 
weakness and wasting of the muscles (1). Symptoms range from difficulty walking and 
muscle cramps to the inability to speak and swallow, and can include paralysis and 
respiratory failure (2). Survival can be between a few months to, exceptionally, decades; 
in most cases, however, patients die within two to five years of diagnosis (1). Currently 
there is no cure available; therefore treatment is focussed on managing symptoms, 
palliative care and optimising quality of life (2). 
A growing body of evidence shows that quality of life in people affected by 
ALS is significantly determined by psychosocial factors such as social support, ability 
to cope, fatigue and depression (3-5). There is a positive relationship between social 
support and quality of life in ALS (4, 6). In other neurological conditions such as 
Parkinson’s disease and multiple sclerosis, reduced social contact is one of the factors 
associated with poor quality of life (7, 8). Social withdrawal is a complex social 
phenomenon often seen to arise from internal factors, with the person affected actively 
choosing to reduce social interaction, potentially due to increased anxiety in social 
situations or embarrassment (9, 10). Social withdrawal in ALS is associated with 
depression (11) and may be a mediator for the effects of fatigue and coping ability on 
quality of life (3).  People with ALS frequently report being socially withdrawn from 
friends and family. Some describe contact with their professional caregivers as their 
most common form of social interaction (10). Understanding risk factors and potential 
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causes for social withdrawal may therefore be a crucial first step to developing 
psychological interventions that lead to improved quality of life.  
In the current study we aim to investigate more closely the association of 
functional status and demographic characteristics with social withdrawal in ALS to 
identify which factors, practicable for routine assessment by clinical staff, might 
highlight patients at risk of social withdrawal. In addition, we investigate whether 
common physical symptoms (drooling, choking, head drop, muscle cramps, muscle 
twitching and emotional lability), anxiety and depression, can provide additional 
information regarding who is at risk of social withdrawal. As embarrassment has been 
identified as one of the key drivers for social withdrawal in ALS (10) we investigate the 
hypothesis that the effects on social withdrawal are mediated by patient perceived 
stigma (see Supplementary Material section S.3 for the hypothesised causal pathway). 
Stigma is defined as an attribute or characteristic that is devalued in a particular social 
context (12). It is a multi-dimensional concept including the domains of enacted and 
internalised stigma, which are measured by the Stigma Scale for Chronic Illness (13) 
that we use in this study. Enacted stigma refers to the experience of negative attitudes 
and unfair treatments by others. If an individual perceives enacted stigma, it can be 
internalised leading to the individual believing that the negative public attitudes or 
stereotypes apply to them. Both enacted and internalised stigma can result in various 





Material and Methods  
Data collection 
Participants were recruited into the ongoing Trajectories of Outcomes in Neurological 
Conditions (TONiC) study from ALS clinics across the United Kingdom.  Following 
informed consent, participants completed a questionnaire pack, for which a caregiver 
could act as scribe if the patient was unable to hold a pen.  Demographic and disease-
specific data, as well as a range of patient reported measures, were collected in the pack. 
Ethical approval was granted from the relevant local research committees (reference  
11/NW/0743). 
Rasch analysis 
All scores from ordinal questionnaires were transformed to interval-level scaling 
through fit of their data to the Rasch model (15). Full details of the approach are 
described elsewhere (16). Briefly, data from the scale should show consistent stochastic 
ordering of items and subjects; items should show local independence (conditioned on 
the raw score) (17); items should be invariant across relevant groups such as age and 
gender (Differential Item Functioning) and the scale (or domains) should be 
unidimensional (18).  
Tables of fit of the Rasch model to the data for all the scales used in the analysis are 




Questionnaire Measures  
Social Withdrawal 
Social Withdrawal was assessed using the 14-item summary scale from the MND-
Social Withdrawal Scale (19) which ranges from 0 to 42 with lower values indicating 
less social withdrawal. The nomogram for conversion of raw scores into interval-level 
scores is shown in the Supplementary Material (section S.2).  
Stigma  
Stigma was assessed using the 8-item Stigma Scale for Chronic Illness (SSCI-8) (13). 
The scale ranges from 0-32. Lower scores indicate less stigma. The nomogram for 
conversion of raw scores into interval-level scores is given in the Supplementary 
Material (section S.2) 
Functional ability 
Functional ability was measured by the 12-item ALS Functional Rating Scale-Revised 
(ALSFRS-R) (20).  The ALSFRS-R has been criticised as multidimensional, with a 
recommendation that it is reported as a profile of scores for Bulbar, Motor Function and 
Respiratory domains, rather than a total score (21). The sub-scales range from 0-12, 0-
24 and 0-12 for the bulbar, motor and respiratory domains, respectively. Lower scores 
indicate greater disability. 
Depression and Anxiety  
The modified 12-item Hospital Anxiety and Depression scale-MND (HADS-MND) . 
(22) was used to assess mood disorders in patients. The anxiety and depression sub-
scales range from 0-18 and 0-16, respectively. Lower scores indicate less anxiety or 
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depression.   
Physical symptoms  
The Symptom Inventory-ALS consists of 6 items, one for each symptom assessed: 
drooling, choking, head drop, cramps, fasciculations and emotional lability.  Each 
symptom is rated according to three levels: ‘I don’t have this’, ‘I have this but it doesn’t 
bother me’ and ‘I have this and it does bother me’ and is treated as a categorical 
variable in the regression analysis.   
Statistical Analysis  
All explanatory variables were standardised before analysis. Significance was assessed 
using the likelihood ratio criterion with p<0.05 as the cut-off for significance. The 
analyses were conducted on complete cases only. All analyses were carried out in R 
version 3.3.1. 
 Simple linear regression analyses were first conducted to assess the individual 
associations of age, sex, onset type, bulbar, motor and respiratory functional deficits 
with social withdrawal.  Through forward selection a multiple regression model was 
then developed and interactions between main effects were tested for significance.  
To assess whether physical symptoms, anxiety and depression give additional 
information for identifying people at risk of social withdrawal, items from the Symptom 
Inventory-ALS and anxiety and depression scores were added to the multiple regression 
model for social withdrawal using forward selection. Interaction effects were tested for 
significance. 
The mediating role of stigma was investigated through the development of a 
joint model for stigma and social withdrawal. In order to estimate the direct effects of 
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covariates on social withdrawal after adjustment for stigma, and to distinguish these 
from indirect effects of covariates on social withdrawal mediated by stigma, the 
bivariate distribution was factorised according to the mediation hypothesis (see 
Supplementary Material section S.3 for the conceptual causal pathway). All explanatory 
variables and interaction terms found to be significant predictors of social withdrawal in 
the previous analysis were included in the initial bivariate model. Non-significant 




632 participants were considered in the current analysis. Out of these, 73 individuals 
were excluded from the analysis due to missing data. Table 1 gives the demographics of 
the remaining study population (N= 559). 
The distributions of social withdrawal and stigma in the study population are 
shown in Figure 1. Social withdrawal was approximately Normally distributed with a 
sample mean and median of 24.79 and 25.2 (on a scale from 0-42), respectively, a 
sample standard deviation of 3.53 and a range of 12.25 to 42. The remaining study 
population was located more centrally along the scale thus indicating that most 
individuals experienced some form of social withdrawal. Section S.4 in the 
Supplementary Material shows the associations of social withdrawal with age, sex, 
onset type and stigma as found in the study population.  
Stigma appeared to follow a bimodal distribution, with 13% of the study 
population not experiencing any stigma and the levels in the remaining population 
approximating a Normal distribution. The sample mean and median level of stigma 
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were 8.85 and 8.36, respectively, on a scale from 0 to 32. The sample standard deviation 
was 5.42. The highest level of stigma was 26.32.  
Table 2 gives the frequencies of the occurrence of those symptoms covered by 
the Symptom Inventory-ALS and the frequency at which the symptoms caused distress 
to those affected. Fasciculations and muscle cramps were the most common symptoms, 
but bothered only a quarter and two fifths of the affected population, respectively. 
Drooling, choking and emotional lability bothered about half of the individuals affected. 
Head drop was experienced by only a quarter of the study population, but bothered two-
thirds of those affected. 
Table 3 gives summary statistics of the remaining variables used in the analysis. 
Are functional deficits and demographic characteristics predictors of social 
withdrawal? 
All three domains of ALSFRS-R (bulbar, motor and respiratory) as well as sex and 
onset-type were significantly associated with social withdrawal in a univariable 
regression analysis. The multiple regression model showed that social withdrawal 
increases with worse motor and bulbar function (-0.31 (95% CI: -0.39,-0.23); -0.31 
(95% CI: -0.39,-0.24), respectively). Motor and bulbar function also had a small but 
significant interaction effect on social withdrawal (-0.08 (95% CI: -0.16, -0.01)), 
indicating that the negative effect of functional ability in each of the domains on social 
withdrawal is further enhanced by the functional ability in the second domain. Age had 
a weak negative association (-0.09 (95% CI: -0.16, -0.01)) with social withdrawal after 
adjusting for the functional deficits. Parameter estimates are given in the Supplementary 
Material, section S.5 Table 1. Age, motor and bulbar function together explained 19% 





Do anxiety and depression scores or the Symptom Inventory-ALS capture 
additional risk factors for social withdrawal? 
Including anxiety, depression and physical symptoms, as recorded by the Symptom 
Inventory-ALS, as explanatory variables in the previously developed model for social 
withdrawal showed that individually, anxiety, depression, emotional lability, 
fasciculation, muscle cramps and choking are significantly associated with social 
withdrawal after adjustment for demographics and functional deficits. In the forward 
selection process, however, none of the symptoms remained significant after adjustment 
for depression and anxiety. Increased social withdrawal was associated with worse 
depressive symptoms (0.26 (95% CI: 0.17, 0.34)) and more anxiety (0.19 (95% CI: 
0.11, 0.27)).  Figure 2 shows that social withdrawal increased with anxiety and 
depression whether or not the patient scores fall above the cut-off levels suggested for 
possible or probable cases (22). Depression also had a small but significant interaction 
effect with the motor domain of the ALSFRS-R; the rate at which social withdrawal 
increases with depression, increases with better functional ability (0.09 (95% CI: 0.02, 
0.16)). Parameter estimates for the full model are given in the Supplementary Material 
section S.4 Table 2. Inclusion of depression and anxiety as predictors for social 
withdrawal increased the adjusted R2 value of the model to 35%. 
 
Could stigma be a mediator for the effects of functional deficits, depression and 
anxiety on social withdrawal? 
13 
 
After removing non-significant effects from the joint model for stigma and social 
withdrawal, direct effects of stigma, bulbar function, motor function, depression and 
anxiety on social withdrawal remained, as well as effects of motor function, bulbar 
function, depression, anxiety, and age on stigma. The previously found interaction 
effect between motor and bulbar function only had a significant effect on stigma. This 
suggests that the effects of motor and bulbar function on stigma are more than additive 
whereas this is not the case for their effects on social withdrawal after stigma is adjusted 
for. The interaction between depression and motor function was only found to have a 
significant direct effect on social withdrawal such that the rate at which social 
withdrawal increases with depression, increases with better functional ability, whereas 
motor function and depression have independent effects on stigma.  
Stigma showed the largest effect on social withdrawal (0.34 (95%CI: 0.27, 
0.42)). There were additional direct effects of comparable sizes for: depression (0.2 
(95% CI: 0.11, 0.28)), motor function (-0.16 (-0.23, -0.1)) and bulbar function (-0.17 (-
0.24, -0.11)). The interaction between depression and motor function showed the 
smallest direct effect (0.09 (95%CI: 0.03, 0.16)). 
Anxiety, bulbar function and age were the three strongest predictors for stigma 
(0.28 (95% CI: 0.2, 0.36), -0.24 (95%CI: -0.31, -0.17) and -0.24 (95%CI: -0.31, -0.18), 
respectively). The other predictors, depression (0.18 (95%CI: 0.1, 0.27)) and motor 
function (-0.14 (95%CI: -0.21, -0.07)), had marginally smaller effects. The parameter 
estimates for this model are given in Table 4. The resulting conceptual pathway is 
shown in Figure 3. Table 5 gives the estimated indirect effects of functional deficits, 
age, anxiety and depression on social withdrawal through stigma. Stigma mediated 
11%-41% of the effect of motor function on social withdrawal and 20% to 50% of the 
effect of bulbar function on social withdrawal. Between 14% and 41% of the effect of 
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depression on social withdrawal was mediated by stigma and for anxiety 28% to 90% of 
the effect was indirect via stigma.  




This is the largest study of social withdrawal in ALS or any neurological 
condition, as previous literature concerns mental health (23, 24) or HIV (25, 26).  
Social withdrawal is widely experienced, to varying degrees, among this large 
cohort of people with ALS recruited across the UK when attending for routine 
clinic follow-up. Using a well validated outcome measure (19), social withdrawal 
appears to follow a Normal distribution with no participant reporting a floor effect 
and only one reporting a ceiling effect. 
Social withdrawal increases with worse motor or bulbar function, and the 
synergistic relation between the two impairments places the patient particularly at 
risk when they experience both.  Anxiety and depression scores both significantly 
increase the risk of social withdrawal, whether or not the patient scores fall above 
the cut-off levels suggested for possible or probable cases (22). Thus, at levels 
which would not lead to a diagnosis of either depression or anxiety, feelings of 
low mood increase the risk of social withdrawal.  This relationship may be 
circular, in that social withdrawal has been reported as part of the experience of 
depression among people with neurological conditions (27) and incurable 
illnesses (28) whilst in longitudinal studies of young people, social withdrawal 
increases the risk of later depression (29). Specific ALS-related symptoms are not 
associated with more social withdrawal once anxiety and depression are taken into 
account. 
Depression and physical disability interact on social withdrawal in a complex 
manner; increasing depression is associated with greater social withdrawal but the rate 
increases with less physical disability.  Clinical experience shows that patients who are 
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depressed and tending to withdraw socially may have to maintain some social contacts 
if their physical disability necessitates them relying on others.  In routine clinical care, 
the patient who is particularly vulnerable to severe social withdrawal has bulbar 
impairment and depression, but sufficiently preserved motor function that they can 
manage without day-to-day assistance.  
Earlier work has shown that stigma is more prevalent in ALS than in multiple 
sclerosis or Parkinson’s disease (13).  Patient-perceived stigma is the strongest single 
predictor for social withdrawal amongst the factors tested here and may partially 
mediate the effects of functional impairments, anxiety and depression.  The joint model 
shows that increased anxiety, impaired bulbar function, and age are the strongest 
predictors for greater feelings of stigma.  The impact of anxiety on stigma has been 
identified in large, multinational studies (30).  The adverse impact of poor bulbar 
function on stigma may be related to the stigmatising effects of altered or lost speech, as 
has been demonstrated in speech disorders like stuttering, or speech loss through 
laryngectomy (31). Clinical services should monitor younger patients with high levels 
of anxiety and depression together with loss of speech or swallowing as they appear at 
particular risk of experiencing stigma and social withdrawal.   
Services in the clinical, patient support and voluntary sectors should foster social 
interaction as a means to ameliorate stigma, depression and social withdrawal.  There 
are no published studies on how to reduce social withdrawal in MND; a recent review 
on reducing social isolation in older people recommended social activity and/or support 
within a group format (32). Large, multinational studies of people with depression 
showed that stigma can co-exist with depression but may be lessened by more social 
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contact (33).   In a longitudinal intervention study, social identification, or the sense of 
being part of a group, predicted recovery from depression (34).   
In this study we have identified predictors for social withdrawal and have built a 
case for a causal pathway from symptoms and disabilities to social withdrawal in which 
self-perceived stigma has a mediating role. However, there are several limitations to 
consider. Due to the cross-sectional nature of this study it is not possible to establish 
any causal direction, we rather assess whether an a priori hypothesised causal pathway 
is in agreement with the data. A second limitation of this study is the omission of 
potentially confounding variables. Omitted variable bias is not a concern for the 
identification of predictors for social withdrawal; it may, however, have large effects on 
the results regarding the causal pathway. The omission of confounding variables may 
produce spurious causal relationships. In particular, when carrying out mediation 
analyses, the omission of variables that affect the exposure and the outcomes, the 
exposure and the mediator, or the mediator and the outcome can give rise to severe 
biases in the estimated direct and indirect effects (e.g. (35-37)). This may be one reason 
why previously published work, which included different variables than in this study, 
did not find a relationship between depression and social withdrawal (3), unlike the 
results shown here.  
Stigma, depression, anxiety, age, bulbar and motor function explain 42% of the 
observed variation in social withdrawal. The role of other factors remains uncertain, 
although research in adults with disabilities suggests that self-esteem is associated with 
both stigma and social avoidance (38). Stigma has an important role in social 
withdrawal, and both of these factors have relevance to quality of life.  Clinicians 
should also be mindful about relationships between stigma, anxiety and depression, 
which may have effects on quality of life beyond those of physical disability alone.  
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Future longitudinal analysis will further examine the causal relationships between 
stigma, anxiety and depression on social withdrawal.   
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Table 1: Demographics of the study Population 
Variable Value/Frequency 
N 559 
Age in years (mean (sd)) 64.72 (10.66) 
Sex = male (%) 343 (61.4) 
Type of onset (%)  
Motor 397 (71.0) 
Bulbar 152 (27.2) 
Respiratory 10 (1.8) 
Time since diagnosis in months (median 
(IQR)) 
11.79 (4.83, 30.58) 
Employment (%)  
working/student 77 (13.8) 
retired 258 (46.2) 
unable to work due to illness 128 (22.9) 
unemployed 6 (1.1) 
other 9 (1.6) 
NA 81 (14.5) 
Marital status (%)  
married 431 (77.1) 
divorced  40 (7.2) 
single  29 (5.2 
widowed 47 (8.4) 












Table 2: Frequency of observed symptoms as listed in the Symptom Inventory-ALS 
where 0 indicates ' I don't have it', 1: 'I have it but it doesn't bother me' and 2: 'I have it 
and it does bother me'. 
Symptom Frequency 
Fasciculations (%)  
0  106 (19.0) 
1  339 (60.6) 
2  114 (20.4) 
Cramps (%)  
0  141 (25.2) 
1  241 (43.1) 
2  177 (31.7) 
Head drop (%)  
0  418 (74.8) 
1  47 (8.4) 
2  94 (16.8) 
Drooling (%)  
0  345 (61.7) 
1  111 (19.9) 
2  103 (18.4) 
Choking (%)  
0  324 (58.0) 
1  116 (20.8) 
2  119 (21.3) 
Emotional Lability (%)  
0  347 (62.1) 
1  108 (19.3) 






Table 3: Summary statistics of the distributions of depression, anxiety and functional 
ability in the study population. 
Variable Range of the scale Observed Median Observed 25%ile, 75%ile 
Depression 0-16 5.73 2.32, 8.26 
Anxiety 0-18 5.41 3.25, 7.85 
ALSFRS-R bulbar 0-12 8.16 5.89, 12 
ALSFRS-R motor 0-24 13.19 9.85, 15.78 




Table 4: Tables of the standardised parameters estimates for the model of the joint 
distribution of social withdrawal and stigma conditional on demographics, functional 
deficits, anxiety and depression (including p-values and 95% confidence intervals) 
 Estimate P-value 2.5 % 97.5 % 
stigma 
Intercept 0.00 9.66E-01 -0.07 0.07 
ALSFRS-R motor -0.14 1.11E-04 -0.21 -0.07 
ALSFRS-R bulbar -0.24 1.83E-11 -0.31 -0.17 
age -0.24 5.81E-12 -0.31 -0.18 
depression 0.18 3.90E-05 0.10 0.27 
anxiety 0.28 1.28E-10 0.20 0.36 
ALSFRS-R motor: 
ALSFRS-R bulbar1 
-0.09 9.27E-03 -0.16 -0.02 
social withdrawal 
Intercept 0.03 4.40E-01 -0.04 0.09 
stigma 0.34 5.25E-18 0.27 0.42 
ALSFRS-R motor -0.16 2.38E-06 -0.23 -0.10 
ALSFRS-R bulbar -0.17 3.13E-07 -0.24 -0.11 
depression 0.20 3.95E-06 0.11 0.28 
anxiety 0.10 2.12E-02 0.01 0.18 
depression: 
ALSFRS-R motor1 
0.09 3.55E-03 0.03 0.16 






Table 5: Table of the estimated indirect effects of function deficits, age, depression and 
anxiety on social withdrawal through sigma. Effects are calculated as a product of the 
effect of the covariate on stigma and the effect of stigma on social withdrawal (39). 
95% Confidence intervals are based on non-parametric bootstrap and are calculated 
using the R package "boot" and the adjusted percentile method therein (40, 41). 
 Estimate 2.5% 97.5% 
ALSFRS-R motor -0.05 -0.08 -0.02 
ALSFRS-R bulbar -0.08 -0.12 -0.05 
age -0.08 -0.13 -0.05 
depression 0.06 0.03 0.11 
anxiety 0.1 0.05 0.15 
ALSFRS-R motor: 
ALSFRS-R bulbar1 
-0.03 -0.06 -0.01 
1 : indicates an interaction 
 
 
